178 related articles for article (PubMed ID: 24996439)
41. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
[TBL] [Abstract][Full Text] [Related]
42. Glycomic alterations are associated with multidrug resistance in human leukemia.
Zhang Z; Zhao Y; Jiang L; Miao X; Zhou H; Jia L
Int J Biochem Cell Biol; 2012 Aug; 44(8):1244-53. PubMed ID: 22579717
[TBL] [Abstract][Full Text] [Related]
43. Impairment of homologous recombination control in a Fanconi anemia-like Chinese hamster cell mutant.
Larminat F; Germanier M; Papouli E; Defais M
Biol Cell; 2004 Sep; 96(7):545-52. PubMed ID: 15380621
[TBL] [Abstract][Full Text] [Related]
44. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
45. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.
Stecklein SR; Jensen RA
Transl Res; 2012 Sep; 160(3):178-97. PubMed ID: 22683426
[TBL] [Abstract][Full Text] [Related]
46. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
47. Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.
Yarde DN; Oliveira V; Mathews L; Wang X; Villagra A; Boulware D; Shain KH; Hazlehurst LA; Alsina M; Chen DT; Beg AA; Dalton WS
Cancer Res; 2009 Dec; 69(24):9367-75. PubMed ID: 19934314
[TBL] [Abstract][Full Text] [Related]
48. Chaetominine reduces MRP1-mediated drug resistance via inhibiting PI3K/Akt/Nrf2 signaling pathway in K562/Adr human leukemia cells.
Yao J; Wei X; Lu Y
Biochem Biophys Res Commun; 2016 May; 473(4):867-873. PubMed ID: 27038543
[TBL] [Abstract][Full Text] [Related]
49. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway.
Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB
Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515
[TBL] [Abstract][Full Text] [Related]
50. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
51. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells.
Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T
Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273
[TBL] [Abstract][Full Text] [Related]
52. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway].
Xiao H; Zhang KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):804-8. PubMed ID: 18718065
[TBL] [Abstract][Full Text] [Related]
53. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.
Villamar Cruz O; Prudnikova TY; Araiza-Olivera D; Perez-Plasencia C; Johnson N; Bernhardy AJ; Slifker M; Renner C; Chernoff J; Arias-Romero LE
Oncotarget; 2016 Nov; 7(47):76590-76603. PubMed ID: 27740936
[TBL] [Abstract][Full Text] [Related]
54. Modifications of oxido-reductase activities in adriamycin-resistant leukaemia K562 cells.
Denis-Gay M; Petit JM; Mazat JP; Ratinaud MH
Biochem Pharmacol; 1998 Aug; 56(4):451-7. PubMed ID: 9763220
[TBL] [Abstract][Full Text] [Related]
55. Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.
Liu H; Liu M; Zhang J; Liang Y
Mol Med Rep; 2020 Oct; 22(4):2810-2816. PubMed ID: 32945422
[TBL] [Abstract][Full Text] [Related]
56. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
57. MERIT40 cooperates with BRCA2 to resolve DNA interstrand cross-links.
Jiang Q; Paramasivam M; Aressy B; Wu J; Bellani M; Tong W; Seidman MM; Greenberg RA
Genes Dev; 2015 Sep; 29(18):1955-68. PubMed ID: 26338419
[TBL] [Abstract][Full Text] [Related]
58. Folic acid supplementation in vitro induces cell type-specific changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA methylation of their promoters or DNA repair.
Price RJ; Lillycrop KA; Burdge GC
Nutr Res; 2015 Jun; 35(6):532-44. PubMed ID: 25960189
[TBL] [Abstract][Full Text] [Related]
59. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1.
Wan L; Tian Y; Zhang R; Peng Z; Sun J; Zhang W
J Cell Biochem; 2018 May; 119(5):3843-3852. PubMed ID: 29058777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]